SI1773829T1 - Amino-tropanski derivati, njihova priprava in njihova terapevtska uporaba - Google Patents

Amino-tropanski derivati, njihova priprava in njihova terapevtska uporaba

Info

Publication number
SI1773829T1
SI1773829T1 SI200530620T SI200530620T SI1773829T1 SI 1773829 T1 SI1773829 T1 SI 1773829T1 SI 200530620 T SI200530620 T SI 200530620T SI 200530620 T SI200530620 T SI 200530620T SI 1773829 T1 SI1773829 T1 SI 1773829T1
Authority
SI
Slovenia
Prior art keywords
amino
preparation
therapeutic use
tropane derivatives
tropane
Prior art date
Application number
SI200530620T
Other languages
English (en)
Inventor
Alain Braun
Bruno Cornet
Gilles Courtemanche
Olivier Crespin
Cecile Pascal
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of SI1773829T1 publication Critical patent/SI1773829T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200530620T 2004-07-29 2005-07-20 Amino-tropanski derivati, njihova priprava in njihova terapevtska uporaba SI1773829T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408372A FR2873693B1 (fr) 2004-07-29 2004-07-29 Derives d'amino-tropane, leur preparation et leur application en therapeutique
EP05790816A EP1773829B1 (fr) 2004-07-29 2005-07-20 Derives d'amino-tropane, leur preparation et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
SI1773829T1 true SI1773829T1 (sl) 2009-06-30

Family

ID=34947491

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530620T SI1773829T1 (sl) 2004-07-29 2005-07-20 Amino-tropanski derivati, njihova priprava in njihova terapevtska uporaba

Country Status (26)

Country Link
US (1) US7569582B2 (sl)
EP (1) EP1773829B1 (sl)
JP (1) JP2008508242A (sl)
KR (1) KR20070047803A (sl)
CN (1) CN101010320B (sl)
AR (1) AR050019A1 (sl)
AT (1) ATE417846T1 (sl)
AU (1) AU2005276355B2 (sl)
BR (1) BRPI0513923A (sl)
CA (1) CA2574517A1 (sl)
CY (1) CY1108878T1 (sl)
DE (1) DE602005011818D1 (sl)
DK (1) DK1773829T3 (sl)
ES (1) ES2319918T3 (sl)
FR (1) FR2873693B1 (sl)
HR (1) HRP20090160T1 (sl)
IL (1) IL180797A (sl)
MX (1) MX2007001023A (sl)
PE (1) PE20060575A1 (sl)
PL (1) PL1773829T3 (sl)
PT (1) PT1773829E (sl)
RU (1) RU2389727C2 (sl)
SI (1) SI1773829T1 (sl)
TW (1) TW200617005A (sl)
UY (1) UY29040A1 (sl)
WO (1) WO2006021657A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873690B1 (fr) * 2004-07-29 2006-10-13 Sanofi Synthelabo Derives d'oxopiperidine, leur preparation et leur application en therapeutique
FR2873691B1 (fr) * 2004-07-29 2006-10-06 Sanofi Synthelabo Derives d'amino-piperidine, leur preparation et leur application en therapeutique
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
PT2305263E (pt) * 2007-06-07 2012-10-22 Novartis Ag Formas amorfas estabilizadas de mesilato de imatinib
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP5476307B2 (ja) * 2007-10-25 2014-04-23 エグゼリクシス， インコーポレイテッド トロパン化合物
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809325B2 (en) 2011-03-08 2014-08-19 Sanofi Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
WO2012120057A1 (de) 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968929A (en) * 1996-10-30 1999-10-19 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9712720A (pt) * 1996-10-30 1999-10-26 Schering Corp Derivados de piperazina como antagÈnicos de neurocinina
JP2004524297A (ja) * 2001-01-23 2004-08-12 イーライ・リリー・アンド・カンパニー メラノコルチン受容体アゴニスト
ATE411021T1 (de) * 2001-07-18 2008-10-15 Merck & Co Inc Überbrückte piperidinderivate als melanocortin- rezeptor-agonisten
WO2003061660A1 (en) * 2002-01-23 2003-07-31 Eli Lilly And Company Melanocortin receptor agonists

Also Published As

Publication number Publication date
US20070191361A1 (en) 2007-08-16
FR2873693A1 (fr) 2006-02-03
WO2006021657A1 (fr) 2006-03-02
RU2007107372A (ru) 2008-09-10
HRP20090160T1 (en) 2009-05-31
AU2005276355A1 (en) 2006-03-02
DK1773829T3 (da) 2009-04-20
IL180797A0 (en) 2007-06-03
EP1773829A1 (fr) 2007-04-18
RU2389727C2 (ru) 2010-05-20
EP1773829B1 (fr) 2008-12-17
KR20070047803A (ko) 2007-05-07
JP2008508242A (ja) 2008-03-21
CY1108878T1 (el) 2014-07-02
US7569582B2 (en) 2009-08-04
PE20060575A1 (es) 2006-08-02
ES2319918T3 (es) 2009-05-14
BRPI0513923A (pt) 2008-05-20
AU2005276355B2 (en) 2011-08-25
MX2007001023A (es) 2007-04-16
CA2574517A1 (fr) 2006-03-02
PT1773829E (pt) 2009-03-26
DE602005011818D1 (de) 2009-01-29
UY29040A1 (es) 2006-02-24
FR2873693B1 (fr) 2006-09-15
IL180797A (en) 2011-02-28
AR050019A1 (es) 2006-09-20
PL1773829T3 (pl) 2009-06-30
CN101010320A (zh) 2007-08-01
ATE417846T1 (de) 2009-01-15
CN101010320B (zh) 2011-11-16
TW200617005A (en) 2006-06-01

Similar Documents

Publication Publication Date Title
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
ZA200701482B (en) Sulphonamide derivatives, their preparation and their therapeutic application
TWI350286B (en) Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
IL177047A0 (en) Oxazole derivatives, preparation and therapeutic use thereof
EP1828223A4 (en) Novel betulin derivatives, their preparation and their use
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
PL1776340T3 (pl) Pochodne B-(1H-indolilo)-1H-indolo-2-karboksyamidów, ich wytwarzanie i zastosowanie ich w lecznictwie
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL182385A0 (en) Pyridine derivatives and the preparation and the therapeutic use thereof
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
IL180867A0 (en) Pyrrole derivatives, their preparation and their therapeutic use
ZA200704806B (en) Novel betulin derivatives, preparation thereof and use thereof
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
SI1525198T1 (sl) Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP